The demand for syringes and needles in GCC countries is predicted to surge at a 5.40% CAGR through 2034. According to the estimates, the syringe and needle industry in GCC is valued at US$ 688.5 million in 2024 and is projected to surpass US$ 1,164.90 million by 2034.
In the Gulf Cooperation Council (GCC) countries, the syringe and needle industry is undergoing shifts due to digital health technologies’ introduction. Technological upgraded devices that allow for real-time drug adherence monitoring, dose accuracy, and patient outcomes improve clinical decision-making and patient involvement. Manufacturers can provide unique solutions that support the region’s digital health activities and enhance patient care and healthcare delivery by utilizing Internet of Things (IoT) platforms, data analytics, and interoperable systems.
Economic growth and urbanization trends in the GCC area drive healthcare expenditures and consumer demand for high-quality healthcare services. Demand for medical equipment increases in tandem with rising disposable income levels and urban population growth. Manufacturers observing economic trends and consumer preferences can capitalize on economic growth opportunities by aligning their product lines with growing healthcare trends. Investing in industry research and localization strategies, and establishing a strong distribution network can help reach target customers effectively. Businesses can achieve long-term growth and leadership in the GCC healthcare sector by capitalizing on demographic trends and consumer behavior patterns.
Key Takeaways from the GCC Syringe and Needle Industry Report:
- The GCC syringe and needle industry size expanded at a 9.10% CAGR from 2019 to 2023.
- The disposable segment holds 80.30% of industry shares in 2024.
- The hypodermic segment captures 85.40% of industry shares in 2024.
- The industry size in the Kingdom of Saudi Arabia is projected to rise at a 5.60% CAGR through 2034.
- The industry size in the United Arab Emirates is anticipated to develop at a 5.70% CAGR through 2034.
- The industry size in Bahrain is estimated to surge at a 4.60% CAGR through 2034.
- The industry size in Oman is expected to increase at a 5.30% CAGR through 2034.
“The syringe and needle industry in GCC depends heavily on innovation, legal compliance, and strategic alliances. In this fast-paced healthcare industry, innovation, adherence to strict rules, and alliance-building are key factors driving development and distinction.” Says a Lead Analyst at Future Market Insights (FMI).
Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!
Competitive Landscape:
The syringe and needle industry in GCC countries is competitive, with considerable global corporations such as Becton, Dickinson, and Company (BD), Terumo Corporation, and Smiths Medical competing with regional players. These firms compete on the basis of product quality, cost, regulatory compliance, and distribution efficiency. Emerging domestic firms and startups contribute to the competitive landscape by promoting innovation and dynamism. Acquisitions, mergers and partnerships are common strategic efforts firms use in the GCC healthcare sector to increase their industry position and capitalize on new possibilities.
Recent Developments:
- In February 2023, Venus Remedies Ltd., a research-based pharmaceutical firm, acquired GMP certification from Saudi Arabia.
- In September 2022, BD (Becton, Dickinson, and Company) launched a next-generation glass pre-fillable syringe (PFS), setting a new benchmark for vaccine PFS performance. The PFS meets stricter criteria for processability, cosmetics, contamination, and integrity.
Key Companies Profiled:
Becton, Dickinson and Company (BD); Terumo Corporation; Smiths Medical; Nipro Corporation; B. Braun Melsungen AG; Cardinal Health, Inc.; Gerresheimer AG; Hindustan Syringes & Medical Devices Ltd. (HMD); Medtronic plc; Fresenius SE & Co. KGaA
Key Segments:
By Product:
- Oral
- Hypodermic
- Standard
- Special Purpose
- Insulin
- Tuberculin
- Other Special Purpose
- Angiographic
By Usability:
- Disposable
- Reusable
By Material:
- Glass
- Polymer
By End User:
- Hospital
- Blood Collection Center
- Diabetic Care Center
- Veterinary Care Center
- Others
By Country:
- Kingdom of Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Qatar
- Bahrain
- Oman
- Kuwait
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
